Status:
RECRUITING
Implementation and Evaluation of a Fear of Cancer Recurrence Screening, Referral and Management Program
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
Health and Medical Research Fund
Conditions:
Fear of Cancer Recurrence
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the process and outcomes of an implementation program designed to implement fear of cancer screening, referral and management into routine cancer care clinics,...
Detailed Description
This study aims to test if a systematic fear of cancer screening program that employs implementation strategies including training, reflecting, evaluating, facilitating and adapting, increases the pro...
Eligibility Criteria
Inclusion
- All patients diagnosed with non-metastatic breast, gynecological, or colorectal cancer, and who have completed primary and adjuvant treatment within the past two years will be eligible for the proposed screening program.
Exclusion
- All cancer patients beyond two years post-treatment; and diagnosed with metastatic cancer or non-breast, non-gynecological, and non-colorectal cancer.
Key Trial Info
Start Date :
July 26 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
1980 Patients enrolled
Trial Details
Trial ID
NCT06181344
Start Date
July 26 2024
End Date
August 31 2026
Last Update
January 13 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
KWH Breast clinic
Hong Kong, Hong Kong
2
QMH department of Surgery
Hong Kong, Hong Kong